Matteo Fornai Selected Research

Ischemia

1/2023	Adenosine signaling as target in cardiovascular pharmacology.
1/2021	NLRP3 inflammasome in cardiovascular diseases: Pathophysiological and pharmacological implications.
7/2020	The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia.
12/2008	Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matteo Fornai Research Topics

Disease

37	Inflammation (Inflammations) 12/2023 - 05/2003
15	Colitis 02/2023 - 05/2003
12	Obesity 03/2023 - 12/2017
12	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 04/2008
6	Pain (Aches) 01/2020 - 01/2006
5	Body Weight (Weight, Body) 03/2023 - 08/2007
5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2019
5	Neoplasms (Cancer) 01/2021 - 09/2014
4	Ischemia 01/2023 - 12/2008
3	Atherosclerosis 01/2023 - 11/2020
3	Sepsis (Septicemia) 01/2019 - 06/2012
3	Stomach Ulcer (Gastric Ulcer) 07/2012 - 03/2009
3	Ulcer 07/2012 - 03/2009
3	Wounds and Injuries (Trauma) 06/2012 - 07/2005
2	Necrosis 12/2023 - 11/2023
2	Fibrosis (Cirrhosis) 02/2023 - 02/2015
2	Hypertension (High Blood Pressure) 01/2023 - 01/2021
2	Myocardial Infarction 01/2023 - 01/2021
2	Heart Failure 01/2023 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2021
2	Infections 05/2022 - 01/2019
2	Cognitive Dysfunction 12/2021 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2019
2	Multiple Sclerosis 11/2020 - 06/2019
2	Rheumatoid Arthritis 11/2020 - 06/2012
2	Crohn Disease (Crohn's Disease) 01/2020 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 06/2019
2	Hypersensitivity (Allergy) 01/2020 - 10/2017
2	Parkinson Disease (Parkinson's Disease) 06/2019 - 02/2016
2	Neuroinflammatory Diseases 06/2019 - 01/2019
2	Hemorrhage 02/2016 - 06/2009
2	Peptic Ulcer (Peptic Ulcers) 02/2009 - 01/2008

Drug/Important Bio-Agent (IBA)

15	Adenosine (Adenocard)FDA LinkGeneric 01/2023 - 02/2006
12	2,4-dinitrobenzenesulfonic acidIBA 02/2023 - 02/2006
10	2,4-dinitrofluorobenzene sulfonic acidIBA 02/2023 - 05/2003
9	InflammasomesIBA 08/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2016
8	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 07/2005
6	CytokinesIBA 01/2020 - 08/2007
5	Dexamethasone (Maxidex)FDA LinkGeneric 06/2021 - 08/2007
5	NucleotidesIBA 01/2021 - 01/2017
5	Leucine (L-Leucine)FDA Link 01/2021 - 01/2017
5	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 04/2008
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2023 - 01/2006
4	Purinergic Receptors (Receptors, Purine)IBA 01/2023 - 04/2008
4	Cholinergic Agents (Cholinergics)IBA 02/2016 - 05/2003
3	Malondialdehyde (Propanedial)IBA 12/2023 - 03/2009
3	Diclofenac (SR 38)FDA LinkGeneric 12/2023 - 07/2005
3	Oncostatin MIBA 10/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2019
3	Infliximab (Remicade)FDA Link 10/2022 - 01/2020
3	EnzymesIBA 01/2021 - 04/2008
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2013 - 03/2005
3	Protein Isoforms (Isoforms)IBA 07/2012 - 01/2006
3	Adenosine DeaminaseIBA 06/2012 - 08/2007
3	AcidsIBA 01/2011 - 05/2003
2	Peroxidase (Myeloperoxidase)IBA 12/2023 - 02/2016
2	Butyrates (Butyrate)IBA 12/2023 - 01/2023
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023 - 01/2020
2	OccludinIBA 12/2023 - 08/2022
2	LigandsIBA 01/2023 - 01/2018
2	vedolizumabIBA 10/2022 - 01/2020
2	2,4-dinitrobenzeneIBA 08/2022 - 01/2020
2	Purinergic P2X4 ReceptorsIBA 08/2022 - 01/2019
2	Sulfonic AcidsIBA 08/2022 - 01/2020
2	CholesterolIBA 10/2021 - 03/2014
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 12/2008
2	LipidsIBA 01/2021 - 02/2016
2	CollagenIBA 01/2020 - 02/2015
2	InterleukinsIBA 01/2020 - 01/2019
2	FlavonoidsIBA 12/2018 - 01/2018
2	AntioxidantsIBA 12/2018 - 01/2018
2	Monoclonal AntibodiesIBA 11/2017 - 01/2010
2	Caspase 3 (Caspase-3)IBA 07/2012 - 03/2009
2	Indomethacin (Indometacin)FDA LinkGeneric 07/2012 - 03/2009
2	SC 560IBA 07/2012 - 06/2006
2	Acetic Acid (Vinegar)FDA LinkGeneric 07/2012 - 03/2009
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 07/2012 - 03/2009
2	VaccinesIBA 01/2012 - 04/2011
2	Proton Pump InhibitorsIBA 01/2011 - 03/2009
2	9-(2-hydroxy-3-nonyl)adenine (EHNA)IBA 11/2010 - 08/2007
2	pyrazoleIBA 11/2010 - 08/2007
2	pyrimidineIBA 11/2010 - 08/2007
2	Paroxetine (Paxil)FDA LinkGeneric 07/2010 - 06/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2006 - 03/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2023
1	lipopolysaccharide-binding proteinIBA 11/2023
1	CurcuminIBA 03/2023
1	Plant ExtractsIBA 03/2023
1	Tight Junction ProteinsIBA 01/2023
1	Volatile Fatty AcidsIBA 01/2023
1	SodiumIBA 01/2023
1	NP-1815-PXIBA 08/2022
1	Sirtuin 1IBA 01/2022
1	Donepezil (Aricept)FDA LinkGeneric 12/2021
1	Substance PIBA 10/2021
1	AMP-Activated Protein KinasesIBA 06/2021
1	acadesineIBA 06/2021

Therapy/Procedure

5	Therapeutics 01/2023 - 11/2017
2	Drug Therapy (Chemotherapy) 11/2017 - 04/2008